AOAC Research Institute certifies Idaho's E.coli O157:H7 test

Idaho Technology, Inc. (ITI) has been granted Performance Tested Methods Status by the AOAC Research Institute (Certificate No. 100901) for its E.coli O157:H7 test used with the R.A.P.I.D.® LT Food Security System (FSS). The assay uses real-time PCR technology to identify the presence of E.coli O157:H7 in raw ground beef and uncooked spinach food samples.

The system marks a milestone in real-time PCR testing of foodborne pathogens as this platform enables detection of E.coli O157:H7 in less than one hour after only eight hours of enrichment. The validation studies on ground beef and spinach prove that the R.A.P.I.D. LT FSS performed as well as or better than traditional culture methods with faster time to result. The complete system provides the easiest end-to-end protocol for PCR-based detection methods, and the E.coli O157:H7 test joins the Idaho Technology Listeria spp. and Salmonella spp. assays as AOAC-RI approved.

“Our objective is to help food processors effectively test for E.coli O157:H7 in order to prevent illness in consumers,” said David Nielsen, ITI vice president of product development. “This new test from Idaho Technology provides easy, accurate and timely pathogen identification to enhance food companies’ productivity.”

The validation of this rapid screening tool for E.coli is an important development for all food manufacturers since E.coli O157:H7 is a major health problem and is estimated to cause infection in more than 70,000 patients a year in the United States alone. The use of an E.coli O157:H7 screening tool that is both rapid and accurate will permit earlier release of products without fear of potential outbreaks or possible food recalls. The assay is intended for use by trained laboratory personnel.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine